Nath Bio-Genes

NATHBIOGEN03 May 2024

Miscellaneous

₹

-2.40 (-1.17%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Nath Bio-Genes

Nath Bio-Genes

Miscellaneous

NATHBIOGEN03 May 2024

₹

-2.40 (-1.17%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
22-Apr-2023	D	The outcome of the Board Meeting held on 22nd April 2023. In continuance to our intimations dated April 15th 2023, after due deliberation the Board of Directors has recommended dividend for financial year 2022-23 of Rs. 2/-(i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company Book Closure and record date for upcoming AGM The registrar of members and share transfer book of the Company will be closed from 25th June 2023 to 30th June 2023 for the purpose of holding Annual General Meeting and Declaration of Dividend. Kindly note that the record date is 23rd June 2023 for the purpose of AGM and Dividend. (As per BSE Announcement Dated on 25/04/2023) Intimation for Change in Book Closure and Record Date (As Per BSE Announcement dated on 23.05.2023)	04-Jul-2023
30-May-2022	D	Nath Bio-Genes (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2022, inter alia, has recommended dividend for financial year 2021-22 of Rs. 2/- (i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company.	23-Jun-2022
24-Jun-2021	D	Nath Bio-Genes (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 24, 2021, inter alia, has recommended dividend for financial year 2020-21 of Rs. 2/- (i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company.	18-Aug-2021
30-Apr-2024	BC	Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve Audited Financial Results for the	08-May-2024
18-Jan-2024	BC	Outcome of Board Meeting The outcome of the Extra-ordinary General Meeting of the Company held on 12th March 2024 (As Per BSE Announcement Dated on 12.03.2024) Extra Ordinary General Meeti	12-Mar-2024
18-Jan-2024	BC	E.G.M.	08-Mar-2024
21-Feb-2024	BC	Source: BSE Announcement PDF	21-Feb-2024
22-Feb-2024	BC	Akash Farms LLP	21-Feb-2024

No Rights has been declared by NATHBIOGEN

Book Closure

Record Date	Split Date	Purpose
08-May-2024	-	Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve Audited Financial Results for the
12-Mar-2024	-	Outcome of Board Meeting The outcome of the Extra-ordinary General Meeting of the Company held on 12th March 2024 (As Per BSE Announcement Dated on 12.03.2024) Extra Ordinary General Meeti
08-Mar-2024	01 Jan'1900	E.G.M.
21-Feb-2024	01 Jan'1900	Source: BSE Announcement PDF
21-Feb-2024	-	Akash Farms LLP

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Nath Bio-Genes (India) Ltd ₹202.00(-2.40/-1.17%)	202.00	-2.40	388.44	24.98	10.21	0.64
MPIL Corporation Ltd ₹805.95(-42.40/-5.00%)	805.95	-42.40	48.36	223.18	73.26	3.13
Jaykay Enterprises Ltd ₹131.20(-2.25/-1.69%)	131.20	-2.25	780.12	154.14	132.13	5.45
Modi Rubber Ltd ₹100.00(+2.35/2.41%)	100.00	+2.35	244.52	62.75	11.08	0.64
FGP Ltd ₹7.07(+0.01/0.14%)	7.07	+0.01	8.40	28.36	0.00	2.63
TCI Industries Ltd ₹1,405.00(+52.65/3.89%)	1,405.00	+52.65	121.71	2.53	0.00	13.19

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	31.74	22.57	235.28	44.92	25.30	21.73
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	31.74	22.57	235.28	44.92	25.30	21.73
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.54	0.06	0.12	0.26	0.06	0.20
Total Income	34.27	22.63	235.40	45.18	25.36	21.93
Total Expenditure	25.95	17.48	198.25	40.83	19.68	16.97
PBIDT	8.32	5.15	37.15	4.34	5.67	4.95
Interest	2.84	2.44	2.76	1.53	2.96	2.75
PBDT	5.48	2.71	34.38	2.81	2.72	2.20
Depreciation	0.76	0.76	0.76	0.99	0.67	0.67
Tax	0.77	0.35	0.22	0.23	0.70	0.06
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	3.96	1.60	33.40	1.59	1.35	1.47
Extra-ordinary Items	2.50	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.46	1.60	33.40	1.59	1.35	1.47

EPS (Unit Curr.)	2.09	0.85	17.58	0.84	0.71	0.77
EPS (Adj) (Unit Curr.)	2.09	0.85	17.58	0.84	0.71	0.77
Calculated EPS (Unit Curr.)	2.08	0.84	17.58	0.84	0.71	0.77
Calculated EPS (Adj) (Unit Curr.)	2.08	0.84	17.58	0.84	0.71	0.77
Calculated EPS (Ann.) (Unit Curr.)	8.33	3.37	70.31	3.35	2.84	3.09
Calculated EPS (Adj) (Ann.) (Unit Curr.)	8.33	3.37	70.31	3.35	2.84	3.09
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	19.00	19.00	19.00	19.00	19.00	19.00
Reserve & Surplus	589.53	585.56	587.75	562.10	559.16	555.19
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	26.21	22.82	15.79	9.66	22.41	22.78
PBDTM(%)	17.27	12.01	14.61	6.26	10.75	10.12
PATM(%)	12.48	7.09	14.20	3.54	5.34	6.76

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	31.74	22.57	235.28	44.99	25.30	21.73
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	31.74	22.57	235.28	44.99	25.30	21.73
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.54	0.06	0.12	0.26	0.06	0.20
Total Income	34.27	22.63	235.40	45.24	25.36	21.93
Total Expenditure	26.09	17.48	198.25	41.05	19.68	16.97
PBIDT	8.18	5.15	37.15	4.19	5.67	4.95
Interest	2.84	2.44	2.76	1.53	2.96	2.75
PBDT	5.35	2.71	34.38	2.66	2.72	2.20
Depreciation	0.76	0.76	0.76	0.99	0.67	0.67
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.77	0.35	0.22	0.23	0.70	0.06
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	3.82	1.61	33.40	1.44	1.35	1.47
Minority Interest After NP	-0.01	-0.01	-0.02	-0.02	0.00	0.00
Net Profit after Minority Interest	3.83	1.62	33.43	1.45	1.35	1.47

Extra-ordinary Items	2.50	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.33	1.62	33.43	1.45	1.35	1.47

EPS (Unit Curr.)	2.02	0.86	17.59	0.77	0.71	0.77
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	19.00	19.00	19.00	19.00	19.00	19.00

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	25.77	22.82	15.79	9.31	22.41	22.78
PBDTM(%)	16.86	12.01	14.61	5.91	10.75	10.12
PATM(%)	12.04	7.13	14.20	3.20	5.34	6.76

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	19.00	19.00	19.00	19.00	19.00	19.00
Reserves Total	554.35	522.97	594.27	538.61	488.58	450.23
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	573.35	541.97	613.27	557.61	507.58	469.23
Secured Loans	104.18	91.07	88.63	63.37	52.33	28.48
Unsecured Loans	1.03	1.88	12.15	6.78	5.82	4.11
Total Debt	105.21	92.95	100.78	70.15	58.15	32.59
Total Liabilities	678.56	634.92	714.05	627.76	565.73	501.82
APPLICATION OF FUNDS :
Gross Block	269.63	267.30	267.28	264.90	249.86	227.93
Less : Accumulated Depreciation	25.25	22.41	20.36	18.87	18.14	16.99
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	244.38	244.89	246.92	246.03	231.72	210.94
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	5.06	5.06	5.05	5.00	5.00	5.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	207.85	220.34	226.30	204.31	155.36	123.46
Sundry Debtors	97.31	85.55	109.39	107.00	108.03	82.05
Cash and Bank	37.98	4.17	29.22	21.98	21.38	44.66
Loans and Advances	177.85	157.74	171.19	139.04	122.41	104.04
Total Current Assets	520.99	467.80	536.10	472.33	407.17	354.21
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	110.75	100.03	69.85	96.38	77.55	64.20
Provisions	0.87	1.97	3.02	3.39	0.90	3.31
Total Current Liabilities	111.62	102.00	72.88	99.77	78.45	67.51
Net Current Assets	409.37	365.80	463.22	372.57	328.73	286.70
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	1.18	1.14	1.03
Deferred Tax Liability	0.00	0.00	0.00	0.49	0.41	0.17
Net Deferred Tax	0.00	0.00	0.00	0.69	0.73	0.86
Total Assets	658.81	615.75	715.20	624.29	566.18	503.50
Contingent Liabilities	71.85	60.59	60.41	52.01	44.65	34.46

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	4.17	29.22	21.98	21.38	44.66
Net Cash from Operating Activities	38.37	17.05	1.11	9.48	-22.94
Net Cash Used In Investing Activities	-2.88	-19.87	-10.28	-14.44	-20.48
Net Cash Used In Financing Activities	-1.67	-22.23	16.40	5.56	20.14
Net Inc./Dec In Cash And Cash Equivalents	33.82	-25.05	7.23	0.61	-23.28
Cash And Cash Equivalents At End Of The Year	37.98	4.17	29.22	21.98	21.38

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

45.60%

FII Shareholding

0.27%

DII Shareholding

4.37%

Public Shareholding

49.76%

**Promoter pledged shareholding 45.60%

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Ltd is in the Miscellaneous sector, having a market capitalization of Rs. 388.44 crores. It has reported a sales of Rs. 31.74 crores and a net profit of Rs. 3.96 crores for the quarter ended December 2018. The company management includes , Satish Kagliwal,Dhiraj Rathi,Jeevanlata Kagliwal,Ashu Jain,Vadla Nagbhushanam,Madhukar Deshpande,HITESH RAJNIKANT PUROHIT,Akash Nandkishor Kagliwal (Nath Bio-Genes (India) Ltd) among others.

Chairman

Registered office

Nath House Nath Road,P B No 318,Aurangabad.,Maharashtra,431005

FAX :91-240-2376188

Background

Incorporation Year1993

Face Value₹10

Market Lot1

How to buy Nath Bio-Genes shares on nse?

To buy Nath Bio-Genes shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Nath Bio-Genes share price today?

The Nath Bio-Genes shares price on nse is Rs.202 today.

What is the market cap of Nath Bio-Genes shares on BSE ?

The company has a market capitalization of Rs.388.44Cr

What is the PE & PB ratio of Nath Bio-Genes shares ?

PE is 10.21 and PB is 0.64

What is the 52 Week High and Low of Nath Bio-Genes shares?

Nath Bio-Genes stock price high: Rs.243.7 Nath Bio-Genes stock price low: Rs.159.4